Activity of rifapentine and its metabolite 25-O-desacetylrifapentine compared with rifampicin and rifabutin against Mycobacterium tuberculosis, Mycobacterium africanum, Mycobacterium bovis and M. bovis BCG.
about
Novel genetic polymorphisms that further delineate the phylogeny of the Mycobacterium tuberculosis complex.Protein binding of rifapentine and its 25-desacetyl metabolite in patients with pulmonary tuberculosis.Population pharmacokinetics of rifapentine and its primary desacetyl metabolite in South African tuberculosis patients.An update on the use of rifapentine for tuberculosis therapy.Preliminary pharmacokinetic study of repeated doses of rifampin and rifapentine in guinea pigsPopulation pharmacokinetics of rifampin in pulmonary tuberculosis patients, including a semimechanistic model to describe variable absorptionPhysiologically Based Pharmacokinetic Model of Rifapentine and 25-Desacetyl Rifapentine Disposition in Humans.Treatment optimization in patients co-infected with HIV and Mycobacterium tuberculosis infections: focus on drug-drug interactions with rifamycins.Rifamycins, Alone and in Combination.Rifapentine for the treatment of latent tuberculosis.Rifampin vs. rifapentine: what is the preferred rifamycin for tuberculosis?Bacteriological and virulence study of a Mycobacterium chimaera isolate from a patient in China.Susceptibility of Mycobacterium bovis BCG vaccine strains to antituberculous antibiotics.Optimization of the rifampin dosage to improve the therapeutic efficacy in tuberculosis treatment using a murine model.Pharmacokinetics of rifapentine at 600, 900, and 1,200 mg during once-weekly tuberculosis therapy.The early bactericidal activities of rifampin and rifapentine in pulmonary tuberculosis.Metabolic Activity Interferometer: A Powerful Tool for Testing Antibiotics
P2860
Q31043162-CD362B3E-7C4C-43CB-98DE-444302C4CE65Q34058356-E2CA960D-D56F-485A-B39F-EF6D23E7A5B8Q34123784-69F83CE8-8C5F-4650-A87A-45B740B704B9Q35084363-C0EC3FF7-0A7E-48BD-8A9D-4B8DC642575DQ36667095-440F5CE6-75A6-479F-8BE5-42B0959D8169Q36702972-DF374A1F-96F8-48AB-A453-4FDF2A8776D8Q37120003-B33738FA-B4A5-4A66-9072-185126049118Q38207924-63A89741-D397-477F-ABFA-E4A966CB2FACQ38857578-45177D55-6C13-461D-A135-3952C737EFD5Q38933165-440AC402-9ED0-45C1-AE7B-92EF1FDDDEBEQ40095703-962AE736-AF69-482F-B018-AA79ADCAF45FQ41435935-CFF59213-B3AE-47AF-8268-25DE8CBD6242Q42111827-AAEC4930-54EB-4670-BEAD-10C286AA6BA7Q42269559-F1A3B5C5-ADC2-4D95-8F5D-04E1E54659C3Q44764112-AA0F59F3-8885-4B07-A460-BC44245A7772Q46417486-B5E16703-400B-486B-B25C-C4E8D99878F6Q58911119-77C72207-C022-485E-8E86-E70E047091B7
P2860
Activity of rifapentine and its metabolite 25-O-desacetylrifapentine compared with rifampicin and rifabutin against Mycobacterium tuberculosis, Mycobacterium africanum, Mycobacterium bovis and M. bovis BCG.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Activity of rifapentine and it ...... terium bovis and M. bovis BCG.
@en
Activity of rifapentine and it ...... terium bovis and M. bovis BCG.
@nl
type
label
Activity of rifapentine and it ...... terium bovis and M. bovis BCG.
@en
Activity of rifapentine and it ...... terium bovis and M. bovis BCG.
@nl
prefLabel
Activity of rifapentine and it ...... terium bovis and M. bovis BCG.
@en
Activity of rifapentine and it ...... terium bovis and M. bovis BCG.
@nl
P2093
P2860
P356
P1476
Activity of rifapentine and it ...... terium bovis and M. bovis BCG.
@en
P2093
P2860
P304
P356
10.1093/JAC/46.4.565
P407
P577
2000-10-01T00:00:00Z